Search / Trial NCT06234787

Continuous Subcutaneous Glucose Monitoring in Critical Patients

Launched by UNIVERSIDAD EUROPEA DE MADRID · Jan 30, 2024

Trial Information

Current as of October 04, 2024

Recruiting

Keywords

Continuous Subcutaneous Glucose Monitoring Critical Care Intensive Care Hypoglycemia

Description

The disturbances in glycemic control, including type 1 and type 2 diabetes, are increasingly prevalent in the general population, with estimates suggesting that this trend will continue for at least the next 20 years. Critically ill patients are particularly predisposed to glycemic alterations due, among other factors, to stress, fasting, infections, and administered treatments. Hyperglycemia is detrimental to critically ill patients. Sustainedly elevated blood glucose levels lead to immunosuppression, hindering leukocyte function, reducing phagocytic capacity, and altering complement func...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * The study will be conducted in patients admitted to the ICU of HLA Moncloa Hospital over four years. Patients admitted to the ICU, undergoing insulin treatment, and having a CGM sensor.
  • * Patients who sign the voluntary consent to participate in the study (Annex 2). If the participant is not in full physical or intellectual capacity to provide their signature on the informed consent, the responsible investigator will request such consent from their direct family member or the person legally designated to make decisions on their behalf regarding health matters. This measure is taken to ensure that the participant\'s rights are respected, and the integrity of the consent process is maintained, even in situations where their decision-making capacity may be compromised.
  • Exclusion Criteria:
  • * Patients from whom information on CGM cannot be obtained for technical reasons.

About Sponsor

The National Institute of Allergy and Infectious Diseases (NIAID, /ˈnaɪ.æd/) is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.

Contacts

JC

Jennifer Cobb

Immunology at National Institute of Allergy and Infectious Diseases (NIAID)

Locations

Madrid, , Spain

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0